Highlighted Text:
Show |
Hide
Full text loading...
Chapter 16 : The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses
Authors:
Marco Colonna1,
Winfried Barchet1
VIEW AFFILIATIONS
HIDE AFFILIATIONS
Affiliations:
1: Department of Pathology and Immunology, Washington University School of Medicine, Box 8118, 660 South Euclid Ave., St. Louis, MO 63110
Content Type: Monograph
Publication Year:
2004
Category: Immunology; Clinical Microbiology
Book DOI:
10.1128/9781555817671
Chapter DOI:
10.1128/9781555817671.ch16
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Preview this chapter:
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap16-1.gif /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap16-2.gif
Abstract:
To achieve self-tolerance, many inhibitory receptors recognize major histocompatibility complex class I (MHC-I) molecules, which are normally expressed on healthy cells. In humans, inhibitory MHC-I receptors include the killer cell immunoglobulin (Ig)-like receptors (KIRs), the leukocyte Ig-like receptors (LILRs), and the CD94/NKG2A heterodimer. This chapter focuses on LILRs and, in particular, on their function during cytomegalovirus (CMV) infection and their ability to regulate adaptive responses during bacterial infection and following organ transplantation. The members of the LILR family--also known as immunoglobulin-like transcript (ILT), leukocyte Ig-like receptor (LIR), monocyte and macrophage Ig-like receptor (MIR), or CD85--include at least 11 distinct molecules, which have either two or four homologous extracellular Ig-like domains of the C2 type. Inhibitory LILRs (LILRB1, LILRB2, LILRB3, LILRB4, and LILRB5) contain long cytoplasmic domains with two to four immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Another group of LILRs (LILRA1, LILRA2, ILT7, ILT8, and ILT11) have short cytoplasmic domains that lack ITIMs or recognizable docking motifs for signaling mediators. If LILRs have evolved under the selective pressure of UL18, one would also expect that UL18 mutates to neutralize this strategy of the host immune system. A recent study suggests that the ability of inhibitory LILRs to regulate the function of antigen-presenting cells (APCs) may be an important mechanism utilized by suppressor T (Ts) cells to induce immunological tolerance.
Citation:
Colonna M, Barchet W.
2004.
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses,
p 301-312.
In
Kaufmann S, Medzhitov R, Gordon S (ed),
The Innate Immune Response to Infection.
ASM Press, Washington, DC.
doi: 10.1128/9781555817671.ch16
Key Concept Ranking
- Major Histocompatibility Complex Class I
- 0.5099426
- Immune Systems
- 0.46859926
- Innate Immune System
- 0.4614759
0.5099426
Figures
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap16-1,webId=/content/author/10.1128/9781555817671.chap16-1,properties={foaf_givenname=Marco, foaf_name=Marco Colonna, foaf_surname=Colonna, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap16-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap16-2,webId=/content/author/10.1128/9781555817671.chap16-2,properties={foaf_givenname=Winfried, foaf_name=Winfried Barchet, foaf_surname=Barchet, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap16-aff1]]}]]
Citation:
Colonna M, Barchet W.
2004.
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses,
p 301-312.
In
Kaufmann S, Medzhitov R, Gordon S (ed),
The Innate Immune Response to Infection.
ASM Press, Washington, DC.
doi: 10.1128/9781555817671.ch16
/content/10.1128/9781555817671.chap16.fig16-1
FIGURE 1
Organization of the human LILR loci on human chromosome 19q13.4. LILR genes are organized in a centromeric and a telomeric gene cluster encoding inhibitory (LILRB3, LILRB5, LILRB2, LILRB1, and LILRB4), activating (ILT8, ILT11, ILT7, LILRA2, LILRA1), and soluble (LILRA3) isoforms.Two further LILR genes are pseudogenes (ILT9, ILT10, ψ). Schematic models of the encoded molecules are also shown. The five inhibitory LILRs comprise two to four extracellular Ig-like domains and signal through two to four ITIMs in the cytoplasmic domain. LILRB1 and LILRB2 recognize all MHC-I molecules but ligands for other inhibitory LILRs remain unknown. LILRA1 is shown as an example for activating LILRs that lack a cytoplasmic signaling domain but associate with the FcRγ adaptor via charged residues in the transmembrane region. FcRγ signals through an ITAM. LILRA3 is lacking cytoplasmic as well as transmembrane domains and is probably secreted as a soluble molecule. LILRs are also known as ILTs, LILRs, MIRs, or CD85. See the official HUGO nomenclature at http://www.gene.ucl.ac.uk/ nomenclature.
10.1128/9781555817671/fig16-1_thmb.gif
10.1128/9781555817671/fig16-1.gif
FIGURE 1
Organization of the human LILR loci on human chromosome 19q13.4. LILR genes are organized in a centromeric and a telomeric gene cluster encoding inhibitory (LILRB3, LILRB5, LILRB2, LILRB1, and LILRB4), activating (ILT8, ILT11, ILT7, LILRA2, LILRA1), and soluble (LILRA3) isoforms.Two further LILR genes are pseudogenes (ILT9, ILT10, ψ). Schematic models of the encoded molecules are also shown. The five inhibitory LILRs comprise two to four extracellular Ig-like domains and signal through two to four ITIMs in the cytoplasmic domain. LILRB1 and LILRB2 recognize all MHC-I molecules but ligands for other inhibitory LILRs remain unknown. LILRA1 is shown as an example for activating LILRs that lack a cytoplasmic signaling domain but associate with the FcRγ adaptor via charged residues in the transmembrane region. FcRγ signals through an ITAM. LILRA3 is lacking cytoplasmic as well as transmembrane domains and is probably secreted as a soluble molecule. LILRs are also known as ILTs, LILRs, MIRs, or CD85. See the official HUGO nomenclature at http://www.gene.ucl.ac.uk/ nomenclature.
Citation:
Colonna M, Barchet W.
2004.
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses,
p 301-312.
In
Kaufmann S, Medzhitov R, Gordon S (ed),
The Innate Immune Response to Infection.
ASM Press, Washington, DC.
doi: 10.1128/9781555817671.ch16
/content/10.1128/9781555817671.chap16.fig16-2
FIGURE 2
Evolving action and counteraction on the host pathogen interface. (I) In the absence of infection, inhibitory MHC-I receptors such as LILRB1 mediate self-tolerance. (II) Viral pathogens such as HCMV are capable of evading recognition by cytotoxic T cells by retaining antigen-presenting MHC-I molecules. Furthermore, they may exploit inhibitory tolerance by expressing a decoy ligand (UL18 for inhibitory LILRB1). (III) Coevolution with a species-specific pathogen may have provided the selective pressure to convert a duplicated receptor gene into a pathogen-specific activating isoform. (IV) Mutations that were identified in the contact residues of the viral decoy indicate a viral strategy to evade specific detection of infected cells by innate effectors. Endogenous molecules in the target cells are shown in black and viral proteins are depicted in gray.
10.1128/9781555817671/fig16-2_thmb.gif
10.1128/9781555817671/fig16-2.gif
FIGURE 2
Evolving action and counteraction on the host pathogen interface. (I) In the absence of infection, inhibitory MHC-I receptors such as LILRB1 mediate self-tolerance. (II) Viral pathogens such as HCMV are capable of evading recognition by cytotoxic T cells by retaining antigen-presenting MHC-I molecules. Furthermore, they may exploit inhibitory tolerance by expressing a decoy ligand (UL18 for inhibitory LILRB1). (III) Coevolution with a species-specific pathogen may have provided the selective pressure to convert a duplicated receptor gene into a pathogen-specific activating isoform. (IV) Mutations that were identified in the contact residues of the viral decoy indicate a viral strategy to evade specific detection of infected cells by innate effectors. Endogenous molecules in the target cells are shown in black and viral proteins are depicted in gray.
Citation:
Colonna M, Barchet W.
2004.
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses,
p 301-312.
In
Kaufmann S, Medzhitov R, Gordon S (ed),
The Innate Immune Response to Infection.
ASM Press, Washington, DC.
doi: 10.1128/9781555817671.ch16
/content/10.1128/9781555817671.chap16.fig16-3
FIGURE 3
Differential expression of LILR on APCs regulates CD4+ T-cell responses and a pattern emerges.TLR signaling in maturing APCs activates NF-κB, leading to the production of IL-12 and to a lesser degree IL-10. APCs activated in this fashion promote a Th1 response. Modlin and colleagues ( Bleharski et al., 2003 ) have shown that coengagement of activating LILRA2 can shift the balance toward enhanced production of IL-10 and a significant reduction in IL-12. CD4+ T cells polarized by IL-10-producing APCs may deviate toward a Th2 phenotype. Strong Th2 bias has also been observed in mice deficient for the inhibitory LILR homolog PIR-B, presumably due to the dominance of activating PIRs (PIR-As). Chang and colleagues (2002) report that the presence of CD8+ CD28– Ts cells induces the expression of inhibitory LILRB2 and LILRB4 on maturing APCs. Inhibitory LILR signals downmodulate NF-κB activity,APCs become tolerogenic, and CD4 T cells cocultured with tolerogenic APCs become unresponsive to further antigenic stimuli.
10.1128/9781555817671/fig16-3_thmb.gif
10.1128/9781555817671/fig16-3.gif
FIGURE 3
Differential expression of LILR on APCs regulates CD4+ T-cell responses and a pattern emerges.TLR signaling in maturing APCs activates NF-κB, leading to the production of IL-12 and to a lesser degree IL-10. APCs activated in this fashion promote a Th1 response. Modlin and colleagues ( Bleharski et al., 2003 ) have shown that coengagement of activating LILRA2 can shift the balance toward enhanced production of IL-10 and a significant reduction in IL-12. CD4+ T cells polarized by IL-10-producing APCs may deviate toward a Th2 phenotype. Strong Th2 bias has also been observed in mice deficient for the inhibitory LILR homolog PIR-B, presumably due to the dominance of activating PIRs (PIR-As). Chang and colleagues (2002) report that the presence of CD8+ CD28– Ts cells induces the expression of inhibitory LILRB2 and LILRB4 on maturing APCs. Inhibitory LILR signals downmodulate NF-κB activity,APCs become tolerogenic, and CD4 T cells cocultured with tolerogenic APCs become unresponsive to further antigenic stimuli.
Citation:
Colonna M, Barchet W.
2004.
The Function of Leukocyte Immunoglobulin-Like Receptors in Self-Tolerance, Viral Recognition, and Regulation of Adaptive Responses,
p 301-312.
In
Kaufmann S, Medzhitov R, Gordon S (ed),
The Innate Immune Response to Infection.
ASM Press, Washington, DC.
doi: 10.1128/9781555817671.ch16
References
/content/book/10.1128/9781555817671.chap16
1.
Allan, D. S.,, M. Colonna,, L. L. Lanier,, T. D. Churakova,, J. S. Abrams,, S. A. Ellis,, A. J. McMichael,, and V. M. Braud. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189: 1149– 1156.
2.
Arase, H.,, and L. L. Lanier. 2002. Virus-driven evolution of natural killer cell receptors. Microbes Infect. 4: 1505– 1512.
3.
Arase, H.,, E. S. Mocarski,, A. E. Campbell,, A. B. Hill,, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323– 1326.
4.
Arm, J. P.,, C. Nwankwo,, and K. F. Austen. 1997. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J. Immunol. 159: 2342– 2349.
5.
Barclay, A. N.,, G. J. Wright,, G. Brooke,, and M. H. Brown. 2002. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23: 285– 290.
6.
Berg, L.,, G. C. Riise,, D. Cosman,, T. Bergstrom,, S. Olofsson,, K. Karre,, and E. Carbone. 2003. LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet 361: 1099– 1101.
7.
Bertone, S.,, F. Schiavetti,, R. Bellomo,, C. Vitale,, M. Ponte,, L. Moretta,, and M. C. Mingari. 1999. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29: 23– 29.
8.
Bleharski, J. R.,, H. Li,, C. Meinken,, T.G. Graeber,, M.-T. Ochoa,, M. Yamamura,, A. Burdick,, E. N. Sarno,, M. Wagner,, M. Rollinghoff,, T. H. Rea,, M. Colonna,, S. Stenger,, B. R. Bloom,, D. Eisenberg,, and R. L. Modlin. 2003. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301: 1527– 1530.
9.
Bluestone, J. A.,, and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253– 257.
10.
Bolland, S.,, and J. V. Ravetch. 1999. Inhibitory pathways triggered by ITIM-containing receptors. Adv. Immunol. 72: 149– 177.
11.
Borges, L.,, and D. Cosman. 2000. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11: 209– 217.
12.
Borges, L.,, M. L. Hsu,, N. Fanger,, M. Kubin,, and D. Cosman. 1997. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159: 5192– 5196.
13.
Braud, V. M.,, and A. J. McMichael. 1999. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. Curr. Top. Microbiol. Immunol. 244: 85– 95.
14.
Brauweiler, A. M.,, I. Tamir,, and J. C. Cambier. 2000. Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP. Immunol. Rev. 176: 69– 74.
15.
Britt, W. J.,, and C. A. Alford,. 1996. Cytomegalovirus, p. 2493– 2524. In B. N. Fields (ed.), Virology, vol. 2. Lippincott-Raven, Philadelphia, Pa.
16.
Cella, M.,, C. Dohring,, J. Samaridis,, M. Dessing,, M. Brockhaus,, A. Lanzavecchia,, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743– 1751.
17.
Chang, C. C.,, R. Ciubotariu,, J. S. Manavalan,, J. Yuan,, A. I. Colovai,, F. Piazza,, S. Lederman,, M. Colonna,, R. Cortesini,, R. Dalla-Favera,, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237– 243.
18.
Chapman, T. L.,, A. P. Heikeman,, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11: 603– 613.
19.
Collaborative Study on the Genetics of Asthma (CSGA). 1997. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat. Genet. 15: 389– 392.
20.
Colonna, M.,, F. Navarro,, T. Bellon,, M. Llano,, P. Garcia,, J. Samaridis,, L. Angman,, M. Cella,, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809– 1818.
21.
Colonna, M.,, J. Samaridis,, M. Cella,, L. Angman,, R. L. Allen,, C. A. O'Callaghan,, R. Dunbar,, G. S. Ogg,, V. Cerundolo,, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096– 3100.
22.
Colonna, M.,, H. Nakajima,, F. Navarro,, and M. Lopez-Botet. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66: 375– 381.
23.
Cosman, D.,, N. Fanger,, L. Borges,, M. Kubin,, W. Chin,, L. Peterson,, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273– 282.
24.
Crocker, P. R. 2002. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12: 609– 615.
25.
Dietrich, J.,, H. Nakajima,, and M. Colonna. 2000. Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells. Microbes Infect. 2: 323– 329.
26.
Dietrich, J.,, M. Cella,, and M. Colonna. 2001. Iglike transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J. Immunol. 166: 2514– 2521.
27.
Fanger, N. A.,, D. Cosman,, L. Peterson,, S. C. Braddy,, C. R. Maliszewski,, and L. Borges. 1998. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28: 3423– 3434.
28.
Goodnow, C. C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93: 2264– 2271.
29.
Hayami, K.,, D. Fukuta,, Y. Nishikawa,, Y. Yamashita,, M. Inui,, Y. Ohyama,, M. Hikida,, H. Ohmori,, and T. Takai. 1997. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272: 7320– 7327.
30.
Ho, L. H.,, T. Uehara,, C. C. Chen,, H. Kubagawa,, and M. D. Cooper. 1999. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA 96: 15086– 15090.
31.
Kubagawa, H.,, P.D. Burrows,, and M.D. Cooper. 1997. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl.Acad. Sci. USA 94: 5261– 5266.
32.
Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16: 359– 393.
33.
Le Bouteiller, P.,, and A. Blaschitz. 1999. The functionality of HLA-G is emerging. Immunol. Rev. 167: 233– 244.
34.
Liu, W. R.,, J. Kim,, C. Nwankwo,, L. K. Ashworth,, and J. P. Arm. 2000. Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4. Immunogenetics 51: 659– 669.
35.
Long, E. O.,, D. F. Barber,, D. N. Burshtyn,, M. Faure,, M. Peterson,, S. Rajagopalan,, V. Renard,, M. Sandusky,, C. C. Stebbins,, N. Wagtmann,, and C. Watzl. 2001. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev. 181: 223– 233.
36.
Lopez-Botet, M.,, M. Llano,, F. Navarro,, and T. Bellon. 2000. NK cell recognition of non-classical HLA class I molecules. Semin. Immunol. 12: 109– 119.
37.
Lopez-Botet, M.,, M. Llano,, and M. Ortega. 2001. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol. Rev. 181: 193– 202.
38.
Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135– 145.
39.
Miller, J. F.,, and G. Morahan. 1992. Peripheral T cell tolerance. Annu. Rev. Immunol. 10: 51– 69.
40.
Mocarski, E. S., 1996. Cytomegaloviruses and their replication, p. 2447– 2492. In B. N. Fields (ed.), Virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
41.
Nakajima, H.,, J. Samaridis,, L. Angman,, and M. Colonna. 1999. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J. Immunol. 162: 5– 8.
42.
Ober, C.,, N. J. Cox,, M. Abney,, A. Di Rienzo,, E. S. Lander,, B. Changyaleket,, H. Gidley,, B. Kurtz,, J. Lee,, M. Nance,, A. Pettersson,, J. Prescott,, A. Richardson,, E. Schlenker,, E. Summerhill,, S. Willadsen,, and R. Parry. 1998. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum. Mol. Genet. 7: 1393– 1398.
43.
Ponte, M.,, C. Cantoni,, R. Biassoni,, A. Tradori- Cappai,, G. Bentivoglio,, C. Vitale,, S. Bertone,, A. Moretta,, L. Moretta,, and M. C. Mingari. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96: 5674– 5679.
44.
Ravetch, J.V.,, and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457– 492.
45.
Ravetch, J. V.,, and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84– 89.
46.
Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455– 458.
47.
Saverino, D.,, M. Fabbi,, F. Ghiotto,, A. Merlo,, S. Bruno,, D. Zarcone,, C. Tenca,, M. Tiso,, G. Santoro,, G. Anastasi,, D. Cosman,, C. E. Grossi,, and E. Ciccone. 2000. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165: 3742– 3755.
48.
Saverino, D.,, A. Merlo,, S. Bruno,, V. Pistoia,, C. E. Grossi,, and E. Ciccone. 2002. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol. 168: 207– 215.
49.
Shiroishi, M.,, K. Tsumoto,, K. Amano,, Y. Shirakihara,, M. Colonna,, V. M. Braud,, D. S. Allan,, A. Makadzange,, S. Rowland-Jones,, B. Willcox,, E.Y. Jones,, P.A. van der Merwe,, I. Kumagai,, and K. Maenaka. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100: 8856– 8861.
50.
Smith, H. R.,, J.W. Heusel,, I. K. Mehta,, S. Kim,, B. G. Dorner,, O. V. Naidenko,, K. Iizuka,, H. Furukawa,, D. L. Beckman,, J. T. Pingel,, A. A. Scalzo,, D. H. Fremont,, and W. M. Yokoyama. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826– 8831.
51.
Sprent, J.,, and H. Kishimoto. 2002. The thymus and negative selection. Immunol. Rev. 185: 126– 135.
52.
Takeda, K.,, T. Kaisho,, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335– 376.
53.
Tortorella, D.,, B. E. Gewurz,, M. H. Furman,, D. J. Schust,, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18: 861– 926.
54.
Trowsdale, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15: 363– 374.
55.
Ujike, A.,, K. Takeda,, A. Nakamura,, S. Ebihara,, K. Akiyama,, and T. Takai. 2002. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat. Immunol. 3: 542– 548.
56.
Venanzi, S.,, G. Malerba,, R. Galavotti,, M. C. Lauciello,, E. Trabetti,, G. Zanoni,, L. Pescollderungg,, L. C. Martinati,, A. L. Boner,, and P. F. Pignatti. 2001. Linkage to atopy on chromosome 19 in north-eastern Italian families with allergic asthma. Clin. Exp. Allergy 31: 1220– 1224.
57.
Vilches, C.,, and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20: 217– 251.
58.
Volz, A.,, H. Wende,, K. Laun,, and A. Ziegler. 2001. Genesis of the ILT/LIR/MIR clusters within the human leukocyte receptor complex. Immunol. Rev. 181: 39– 51.
59.
Willcox, B. E.,, L. M. Thomas,, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913– 919.
60.
Young, N. T.,, F. Canavez,, M. Uhrberg,, B. P. Shum,, and P. Parham. 2001a. Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex. Immunogenetics 53: 270– 278.
61.
Young, N. T.,, M. Uhrberg,, J. H. Phillips,, L. L. Lanier,, and P. Parham. 2001b. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166: 3933– 3941.